You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (3) |
Back to Search
Meta-analysia of combining rh-endostatin with chemotherapy in treatment of patients with nsclc
- In: Pharmacoepidemiology/Pharmacoeconomics Posters
- At: Lisbon (Portugal) (2010)
- Type: Poster
- Poster code: PP-P-005
- By: CHEN, Baicheng (The 303 Hospital of PLA, China, Nanning, China)
- Co-author(s): Zhang, Qi (The 303 Hospital of PLA, China, NANNING, China)
Xia, Aijun (The 303 Hospital of PLA, China, NANNING, China) - Abstract:
Objective In order to evaluate the efficacy of combining rh-endostatin with Chemo- therapy for non-small cell lung cancer(NSCLC) compared with chemotherapy alone. Methods The randomized clinical trials(RCTs) that compared the efficacy of combining rh-endostatin with Chemotherapy and chemotherapy alone form 2000 to 2004. A meta-analysis was..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026